Search Results - "Chien, Kelly Sharon" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure

A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure

by Chien, Kelly Sharon, Rodriguez-Sevilla, Juan Jose, Alvarado Valero, Yesid, Bravo, Guillermo Montalban, Hammond, Danielle, Swaminathan, Mahesh, Bazinet, Alexandre, Kimberley, Jacqueline, Bodden, Kristy, Schneider, Heather, Dong, Xiao Qin, Pierce, Sherry, Huang, Xuelin, Jabbour, Elias, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

Genomic evolution of patients with myeloid neoplasms and known antecedent clonal hematopoiesis

Genomic evolution of patients with myeloid neoplasms and known antecedent clonal hematopoiesis

by Braish, Julie, Li, Ziyi, Loghavi, Sanam, Montalban-Bravo, Guillermo, Sasaki, Koji, Takahashi, Koichi, Dinardo, Courtney Denton, Hammond, Danielle, Swaminathan, Mahesh, Bazinet, Alexandre, Volpe, Virginia Olivia, Weeks, Lachelle Dawn, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Chien, Kelly Sharon
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

$Results of a phase 1 trial of azacitidine with venetoclax in relapsed/refractory higher-risk myelodysplastic syndrome (MDS)$

Results of a phase 1 trial of azacitidine with venetoclax in relapsed/refractory higher-risk myelodysplastic syndrome (MDS)

by Desikan, Sai Prasad, Montalban-Bravo, Guillermo, Ohanian, Maro, Daver, Naval Guastad, Kadia, Tapan M., Venugopal, Sangeetha, Chien, Kelly Sharon, Kanagal-Shamanna, Rashmi, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

A phase 2 study of the combination of decitabine (DAC), venetoclax (VEN), and ponatinib in patients (Pts) with chronic myeloid leukemia (CML) in accelerated phase (AP)/myeloid blast phase (MBP) or Philadelphia-chromosome positive (Ph+) acute myeloid leukemia (AML)

A phase 2 study of the combination of decitabine (DAC), venetoclax (VEN), and ponatinib in patients (Pts) with chronic myeloid leukemia (CML) in accelerated phase (AP)/myeloid blast phase (MBP) or Philadelphia-chromosome positive (Ph+) acute myeloid leukemia (AML)

by Senapati, Jayastu, Ravandi, Farhad, Dinardo, Courtney Denton, Issa, Ghayas C., Sasaki, Koji, Konopleva, Marina, Macaron, Walid, Nasr, Lewis Fady, Zoghbi, Marianne, Nasnas, Cedric Christophe, Pemmaraju, Naveen, Chien, Kelly Sharon, Ohanian, Maro, Jabbour, Elias, Maiti, Abhishek, Kantarjian, Hagop M., Short, Nicholas James
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Outcomes of individuals with clonal hematopoiesis evaluated at a cancer center

Outcomes of individuals with clonal hematopoiesis evaluated at a cancer center

by Chien, Kelly Sharon, Ong, Faustine, Kim, Kunhwa, Li, Ziyi, Kanagal-Shamanna, Rashmi, Dinardo, Courtney Denton, Takahashi, Koichi, Montalban-Bravo, Guillermo, Hammond, Danielle, Sasaki, Koji, Pierce, Sherry, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Effect of Digital Health Coaching on Self-Efficacy and Patient Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled Trial

Effect of Digital Health Coaching on Self-Efficacy and Patient Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled Trial

by Marvin-Peek, Jennifer, Shelton, Valerie, Brassil, Kelly, Fellman, Bryan, Barr, Austin, Chien, Kelly Sharon, Hammond, Danielle, Swaminathan, Mahesh, Jain, Nitin, Wierda, William, Ferrajoli, Alessandra, DiNardo, Courtney
Published in Acta haematologica (11.06.2024)

Get more information

Journal Article

Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes

Impact of complete cytogenetic response on survival in patients with myelodysplastic syndromes

by Urrutia, Samuel, Sasaki, Koji, Kantarjian, Hagop M., Jabbour, Elias, Chien, Kelly Sharon, Hammond, Danielle, Bueso-Ramos, Carlos E., Khoury, Joseph, Patel, Keyur P., Montalban-Bravo, Guillermo, Wei, Yue, Colla, Simona, Short, Nicholas James, Daver, Naval Guastad, Borthakur, Gautam, Kadia, Tapan M., Pierce, Sherry, Wierda, William G., Garcia-Manero, Guillermo
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

$Subgroup analysis from a phase II trial of ponatinib and blinatumomab in relapsed/refractory (R/R) Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast phase$

Subgroup analysis from a phase II trial of ponatinib and blinatumomab in relapsed/refractory (R/R) Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast phase

by Zoghbi, Marianne, Jabbour, Elias, Haddad, Fadi, Short, Nicholas James, Nasnas, Cedric Christophe, Macaron, Walid, Nasr, Lewis Fady, Jain, Nitin, Montalban-Bravo, Guillermo, Kadia, Tapan M., Daver, Naval Guastad, Chien, Kelly Sharon, Alvarado Valero, Yesid, Issa, Ghayas C., Mayor, Ejiroghene, Deen, Wuliamatu, Thankachan, Jennifer, Garris, Rebecca, Ravandi, Farhad, Kantarjian, Hagop M.
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

$Mini-hyper-CVD with venetoclax (Ven) for patients with relapsed/refractory (R/R) Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL): A phase II study$

Mini-hyper-CVD with venetoclax (Ven) for patients with relapsed/refractory (R/R) Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL): A phase II study

by Zoghbi, Marianne, Jabbour, Elias, Haddad, Fadi, Short, Nicholas James, Senapati, Jayastu, Macaron, Walid, Nasnas, Cedric Christophe, Nasr, Lewis Fady, Pemmaraju, Naveen, Jain, Nitin, Wierda, William G., Borthakur, Gautam, Bravo, Guillermo Montalban, Ravandi, Farhad, Garcia-Manero, Guillermo, Kadia, Tapan M., Chien, Kelly Sharon, Thankachan, Jennifer, Garris, Rebecca, Kantarjian, Hagop M.
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Phase II study of lower-intensity frontline therapy for newly diagnosed patients with AML who are unfit or otherwise not eligible for frontline clinical trials

Phase II study of lower-intensity frontline therapy for newly diagnosed patients with AML who are unfit or otherwise not eligible for frontline clinical trials

by Venugopal, Sangeetha, Jabbour, Elias, Pemmaraju, Naveen, Montalban-Bravo, Guillermo, Chien, Kelly Sharon, Daver, Naval Guastad, Jain, Nitin, Burger, Jan Andreas, Alvarado Valero, Yesid, Maiti, Abhishek, Dinardo, Courtney Denton, Borthakur, Gautam, Malla, Rashmi, Garcia-Manero, Guillermo, Ravandi, Farhad, Kantarjian, Hagop M., Kadia, Tapan M.
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Phase 2 study of azacitidine (AZA) and venetoclax (VEN) as maintenance therapy for acute myeloid leukemia (AML) patients in remission

Phase 2 study of azacitidine (AZA) and venetoclax (VEN) as maintenance therapy for acute myeloid leukemia (AML) patients in remission

by Bazinet, Alexandre, Kantarjian, Hagop M., Borthakur, Gautam, Yilmaz, Musa, Bose, Prithviraj, Jabbour, Elias, Alvarado Valero, Yesid, Chien, Kelly Sharon, Pemmaraju, Naveen, Takahashi, Koichi, Short, Nicholas James, Daver, Naval Guastad, Issa, Ghayas C., Jain, Nitin, Bull-Linderman, Debra, Dinardo, Courtney Denton, Garcia-Manero, Guillermo, Sasaki, Koji, Ravandi, Farhad, Kadia, Tapan M.
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

by Short, Nicholas James, Kantarjian, Hagop M., Konopleva, Marina, Bravo, Guillermo Montalban, Ravandi, Farhad, Jain, Nitin, Kadia, Tapan M., Alvarado Valero, Yesid, Chien, Kelly Sharon, Daver, Naval Guastad, Macaron, Walid, Sasaki, Koji, Thankachan, Jennifer, Delumpa, Ricardo, Mayor, Ejiroghene, Deen, Wuliamatu, Loiselle, Christopher, Kwari, Monica, Garris, Rebecca, Jabbour, Elias
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

Phase II study of cladribine, idarubicin, cytarabine (CLIA) plus gilteritinib in patients (pts) with FLT3 mutated acute myeloid leukemia (AML)

Phase II study of cladribine, idarubicin, cytarabine (CLIA) plus gilteritinib in patients (pts) with FLT3 mutated acute myeloid leukemia (AML)

by Abuasab, Tareq, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Bravo, Guillermo Montalban, Alvarado Valero, Yesid, Daver, Naval Guastad, Yilmaz, Musa, Pemmaraju, Naveen, Chien, Kelly Sharon, Kornblau, Steven Mitchell, Burger, Jan Andreas, Jain, Nitin, Islam, Rabiul, Dinardo, Courtney Denton, Borthakur, Gautam, Jabbour, Elias, Ravandi, Farhad, Kadia, Tapan M.
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

LILRB4 expression in CMML and MDS based on response to hypomethylating agents

LILRB4 expression in CMML and MDS based on response to hypomethylating agents

by Chien, Kelly Sharon, Class, Caleb A., Montalban-Bravo, Guillermo, Sasaki, Koji, Naqvi, Kiran, Ganan Gomez, Irene, Wei, Yue, Yang, Hui, Kanagal-Shamanna, Rashmi, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Patterns of leukemic transformation in patients with TP53 -mutant myelodysplastic syndromes

Patterns of leukemic transformation in patients with TP53 -mutant myelodysplastic syndromes

by Chien, Kelly Sharon, Benton, Christopher Brent, Class, Caleb A., Kadia, Tapan M., Dinardo, Courtney Denton, Konopleva, Marina, Andreeff, Michael, Sasaki, Koji, Naqvi, Kiran, Ganan Gomez, Irene, Wei, Yue, Yang, Hui, Pierce, Sherry A., Patel, Keyur P., Kanagal-Shamanna, Rashmi, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Montalban-Bravo, Guillermo
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm

Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm

by Bataller, Alex, Gener-Ricos, Georgina, Almanza-Huante, Emmanuel, Chien, Kelly S., Urrutia, Samuel, Bazinet, Alexandre, Rodriguez-Sevilla, Juan Jose, Hammond, Danielle, Sasaki, Koji, Takahashi, Koichi, DiNardo, Courtney D., Ravandi, Farhad, Borthakur, Gautam, Kadia, Tapan M., Kanagal-Shamanna, Rashmi, Kantarjian, Hagop M., Garcia-Manero, Guillermo, Montalban-Bravo, Guillermo
Published in Blood advances (11.06.2024)

Get full text

Journal Article

Photo quiz. To scan or not to scan?

Photo quiz. To scan or not to scan?

by Farmakiotis, Dimitrios, Chien, Kelly Sharon, Shum, Thomas Chung Tong, Rodriguez-Barradas, Maria, Musher, Daniel M
Published in Clinical infectious diseases (01.04.2013)

Get full text

Journal Article

To Scan or Not to Scan?

To Scan or Not to Scan?

by Mackowiak, Philip A.
Published in Clinical infectious diseases (01.04.2013)

Get full text

Journal Article

Photo Quiz: To Scan or Not to Scan?

Photo Quiz: To Scan or Not to Scan?

by Farmakiotis, Dimitrios, Chien, Kelly Sharon, Shum, Thomas Chung Tong, Rodriguez-Barradas, Maria, Musher, Daniel M.
Published in Clinical infectious diseases (01.04.2013)

Get full text

Journal Article